BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25164155)

  • 1. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation.
    Özcan E; Saygun NI; Serdar MA; Kurt N
    Clin Oral Investig; 2015 May; 19(4):921-8. PubMed ID: 25164155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary visfatin concentrations in patients with chronic periodontitis.
    Tabari ZA; Azadmehr A; Nohekhan A; Naddafpour N; Ghaedi FB
    J Periodontol; 2014 Aug; 85(8):1081-5. PubMed ID: 24228809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary, gingival crevicular fluid and serum levels of ghrelin and chemerin in patients with periodontitis and overweight.
    Jentsch HFR; Arnold N; Richter V; Deschner J; Kantyka T; Eick S
    J Periodontal Res; 2017 Dec; 52(6):1050-1057. PubMed ID: 28631313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of non-surgical periodontal treatment on three salivary adipokines in diabetic patients with periodontitis.
    Ziaei N; Golmohammadi S; Ataee M; Ardalani F; Mesgari Abbasi M
    J Dent Res Dent Clin Dent Prospects; 2020; 14(3):199-205. PubMed ID: 33408827
    [No Abstract]   [Full Text] [Related]  

  • 5. Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease.
    Pradeep AR; Raghavendra NM; Prasad MV; Kathariya R; Patel SP; Sharma A
    J Periodontol; 2011 Sep; 82(9):1314-9. PubMed ID: 21309715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus.
    Patnaik K; Pradeep AR; Nagpal K; Karvekar S; Singh P; Raju A
    J Investig Clin Dent; 2017 Feb; 8(1):. PubMed ID: 26224661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of non-surgical periodontal treatment on visfatin and chemerin concentration in the gingival crevicular fluid.
    Bengi VU; Özcan E; Saygun NI; Guler OS; Serdar MA
    Odontology; 2024 Jan; 112(1):200-207. PubMed ID: 36976366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Non-surgical Periodontal Therapy on Saliva and Gingival Crevicular Fluid Levels of Chemerin in Periodontitis Subjects With and Without Type 2 Diabetes Mellitus.
    Gd G; S G; Sudhakar U; Raghavan A; Narayan KV
    Cureus; 2023 Jan; 15(1):e33388. PubMed ID: 36751175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary visfatin concentrations in patients with chronic periodontitis: An analysis before and after periodontal therapy.
    Mopidevi A; Penmetsa GS; Dwarkanath CD; Dubba K; Gadde P
    Indian J Dent Res; 2019; 30(6):864-869. PubMed ID: 31939362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Surgical Periodontal Therapy Reduces Saliva Adipokine and Matrix Metalloproteinase Levels in Periodontitis.
    Özcan E; Işıl Saygun N; Serdar MA; Umut Bengi V; Kantarcı A
    J Periodontol; 2016 Aug; 87(8):934-43. PubMed ID: 26991485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary bactericidal/permeability-increasing protein: A novel inflammatory marker associated with periodontitis.
    Demirci MB; Daltaban Ö; Üstün K
    Clin Oral Investig; 2023 Jun; 27(6):3159-3167. PubMed ID: 36805805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease.
    Çetiner D; Uraz A; Öztoprak S; Akça G
    J Appl Oral Sci; 2019 Jul; 27():e20180365. PubMed ID: 31365708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemerin as a Novel Crevicular Fluid Marker of Patients With Periodontitis and Type 2 Diabetes Mellitus.
    Doğan ŞB; Ballı U; Dede FÖ; Sertoğlu E; Tazegül K
    J Periodontol; 2016 Aug; 87(8):923-33. PubMed ID: 26991487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
    Martinez GL; Majster M; Bjurshammar N; Johannsen A; Figueredo CM; Boström EA
    J Periodontol; 2017 Aug; 88(8):e140-e149. PubMed ID: 28474967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?
    Kemer Doğan ES; Duran N
    Clin Oral Investig; 2022 Aug; 26(8):5351-5358. PubMed ID: 35451654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of Salivary Visfatin Levels in Healthy and Periodontally Diseased Patients before and after Scaling and Root Planing.
    Saseendran G; Abraham S; Nair AM; Reejamol MK
    J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S624-S628. PubMed ID: 34447167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Visfatin (Adipocytokine) Biomarker in Oral Health and Diseases among Nonobese Indian Population: A Proteomic Assay.
    Coutinho A; Reddy N; Chatterjee A; Khan MI
    Glob Med Genet; 2021 Sep; 8(3):104-108. PubMed ID: 34430962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
    Keles Yucel ZP; Afacan B; Emingil G; Tervahartiala T; Kose T; Sorsa T
    J Periodontal Res; 2020 Dec; 55(6):887-894. PubMed ID: 32790178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of salivary procalcitonin levels in different periodontal diseases.
    Hendek MK; Erdemir EO; Kisa U
    J Periodontol; 2015 Jun; 86(6):820-6. PubMed ID: 25703733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary biomarkers in a biofilm overgrowth model.
    Morelli T; Stella M; Barros SP; Marchesan JT; Moss KL; Kim SJ; Yu N; Aspiras MB; Ward M; Offenbacher S
    J Periodontol; 2014 Dec; 85(12):1770-8. PubMed ID: 25079398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.